Reproductive functions in female patients treated with adjuvant and neoadjuvant chemotherapy for localized osteosarcoma of the extremity
Autor: | Simone Petracchi, Alessandra Longhi, Gaetano Bacci, B A Michela Versari, Lucia Conticini, Eleonora Porcu |
---|---|
Rok vydání: | 2000 |
Předmět: |
Adult
Cancer Research Pediatrics medicine.medical_specialty Adolescent medicine.drug_class medicine.medical_treatment Bone Neoplasms Antimetabolite Pregnancy Antineoplastic Combined Chemotherapy Protocols medicine Humans Full Term Osteosarcoma Chemotherapy Ifosfamide business.industry Reproduction Puberty Pregnancy Outcome Cancer Extremities Middle Aged medicine.disease Neoadjuvant Therapy Surgery Oncology Chemotherapy Adjuvant Female Amenorrhea medicine.symptom Complication business Follow-Up Studies medicine.drug |
Zdroj: | Cancer. 89:1961-1965 |
ISSN: | 1097-0142 0008-543X |
DOI: | 10.1002/1097-0142(20001101)89:9<1961::aid-cncr12>3.3.co;2-# |
Popis: | BACKGROUND The side effects of chemotherapy on ovarian and reproductive functions in female patients who received adjuvant and/or neoadjuvant treatment for localized osteosarcoma of the extremities at our institution in the last 21 years (1974–1995) were assessed. METHODS Ninety-two patients with a mean actual age of 26 (14–51) were interviewed. They had been followed 3 to 16 years after treatment (mean: 9.6 yrs). Twenty-four of them had received chemotherapy before puberty and 68 after puberty. RESULTS Amenorrhea during chemotherapy occurred in 69% of postpuberal patients but only in 2 patients aged 39 and 43, respectively, was permanent. After the end of treatment, the patients' menstrual activity started again, and only a slight number of cases showed increases of menstrual irregularities. Twenty-two patients married after treatment; 20 patients started a pregnancy at a mean age of 27. Of these 20 patients, 3 had voluntary abortions and 17 succeeded. At the time of article submission, three were pregnant, 14 had 19 full term pregnancies, and no birth defects nor congenital anomalies were registered in their 19 full term newborns. CONCLUSIONS In this group of female patients, chemotherapy seemed to alter neither their reproductive function nor the health of their newborns. Cancer 2000;89:1961–5. © 2000 American Cancer Society. |
Databáze: | OpenAIRE |
Externí odkaz: |